Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Alpine Immune Sciences to Participate in Fireside Chat at the Evercore ISI 3rd Annual HealthCONx Virtual Conference


Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced that members of the Alpine senior leadership team will participate in an analyst-led fireside chat at the Evercore ISI 3rd Annual HealthCONx Virtual Conference on Thursday, December 3, 2020, at 4:45 p.m. ET/1:45 p.m. PT.

A live webcast of the presentation will be available online in the investor relations section of the company's website at https://ir.alpineimmunesciences.com/events. A replay of the presentation will be available on the company website for 90 days following the webcast.

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is creating first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients' lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

"Secreted Immunomodulatory Proteins", "SIP", "Transmembrane Immunomodulatory Protein," "TIP," "Variant Ig Domain," "vIgD" and the Alpine logo are registered trademarks or trademarks of Alpine Immune Sciences, Inc. in various jurisdictions.


These press releases may also interest you

at 07:35
IonQ Unanimously Appoints Peter Chapman as Next Chairman of the Board of Directors
IonQ , a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ's upcoming Annual...

at 07:35
Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:25
Sanborn's Broadband Navigatortm is Available for Streamlined Purchase on NASPO
Are you fully prepared to complete your BEAD State Challenge Process? If not, your path to success just got easier. The Sanborn Map Company's (Sanborn) Broadband Navigatortm is now available on the NASPO ValuePoint cooperative purchasing program...

at 07:21
Lynk & Co's EM-P Takes Center Stage at Beijing Auto Show
Lynk & Co captivated visitors at the Beijing Auto Show with its EM-P, a plug-in hybrid electric vehicle (PHEV) powertrain based on the Lynk E-Motive platform. The EM-P, showcased in models such as the 06EM-P, 07EM-P, 08EM-P, and 09EM-P, garnered...

at 07:18
135th Canton Fair Provides Hassle-free Payment Services for Global Visitors
In a significant move to facilitate seamless payment experiences for international attendees, the 135th China Import and Export Fair ("Canton Fair" or "the Fair") has partnered with multiple financial institutions to upgrade its payment systems. This...

at 07:09
HITACHI ACQUIRES MA MICRO AUTOMATION OF GERMANY IN EFFORT TO ACCELERATE GLOBAL EXPANSION OF ROBOTIC SI BUSINESS IN THE MEDICAL AND OTHER FIELDS
Hitachi Ltd. (TSE: 6501, "Hitachi") has signed a stock purchase agreement on April 26 to acquire all shares of MA micro automation GmbH ("MA micro automation", headquartered in St. Leon-Rot, Germany) from MAX Management GmbH (a subsidiary of MAX...

More news about Science and technology...


News published on and distributed by: